1
|
Annett RD, Chervinskiy S, Chun TH, Cowan K, Foster K, Goodrich N, Hirschfeld M, Hsia DS, Jarvis JD, Kulbeth K, Madden C, Nesmith C, Raissy H, Ross J, Saul JP, Shiramizu B, Smith P, Sullivan JE, Tucker L, Atz AM. IDeA States Pediatric Clinical Trials Network for Underserved and Rural Communities. Pediatrics 2020; 146:peds.2020-0290. [PMID: 32943534 PMCID: PMC7786822 DOI: 10.1542/peds.2020-0290] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 07/16/2020] [Indexed: 01/19/2023] Open
Abstract
The National Institutes of Health's Environmental Influences on Child Health Outcomes (ECHO) program aims to study high-priority and high-impact pediatric conditions. This broad-based health initiative is unique in the National Institutes of Health research portfolio and involves 2 research components: (1) a large group of established centers with pediatric cohorts combining data to support longitudinal studies (ECHO cohorts) and (2) pediatric trials program for institutions within Institutional Development Awards states, known as the ECHO Institutional Development Awards States Pediatric Clinical Trials Network (ISPCTN). In the current presentation, we provide a broad overview of the ISPCTN and, particularly, its importance in enhancing clinical trials capabilities of pediatrician scientists through the support of research infrastructure, while at the same time implementing clinical trials that inform future health care for children. The ISPCTN research mission is aligned with the health priority conditions emphasized in the ECHO program, with a commitment to bringing state-of-the-science trials to children residing in underserved and rural communities. ISPCTN site infrastructure is critical to successful trial implementation and includes research training for pediatric faculty and coordinators. Network sites exist in settings that have historically had limited National Institutes of Health funding success and lacked pediatric research infrastructure, with the initial funding directed to considerable efforts in professional development, implementation of regulatory procedures, and engagement of communities and families. The Network has made considerable headway with these objectives, opening two large research studies during its initial 18 months as well as producing findings that serve as markers of success that will optimize sustainability.
Collapse
Affiliation(s)
- Robert D. Annett
- Department of Pediatrics, University of Mississippi Medical Center, Jackson, Mississippi
| | - Sheva Chervinskiy
- Data Coordinating and Operations Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas
| | - Thomas H. Chun
- Departments of Emergency Medicine and Pediatrics, Brown University, Providence, Rhode Island
| | - Kelly Cowan
- University of Vermont Medical Center, Burlington, Vermont
| | | | | | | | - Daniel S. Hsia
- Pennington Biomedical Research Center, Baton Rouge, Louisiana
| | | | - Kurtis Kulbeth
- Data Coordinating and Operations Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas
| | - Christi Madden
- The Children’s Hospital at University of Oklahoma Medical Center, Oklahoma City, Oklahoma
| | | | - Hengameh Raissy
- University of New Mexico Health Sciences Center, Albuquerque, New Mexico
| | - Judith Ross
- Nemours/Alfred I. duPont Hospital for Children, Wilmington, Delaware
| | - J. Philip Saul
- Department of Pediatrics, West Virginia University, Morgantown, West Virginia
| | - Bruce Shiramizu
- Departments of Tropical Medicine, Pediatrics, and Medicine, University of Hawai’i, Honolulu, Hawaii
| | - Paul Smith
- Department of Pediatrics, University of Montana, Missoula, Montana
| | - Janice E. Sullivan
- Department of Pediatrics, University of Louisville, Louisville, Kentucky; and
| | - Lauren Tucker
- Department of Pediatrics, University of Mississippi Medical Center, Jackson, Mississippi
| | - Andrew M. Atz
- Medical University of South Carolina, Charleston, South Carolina
| |
Collapse
|
2
|
Kempe A, O'Leary ST, Markowitz LE, Crane LA, Hurley LP, Brtnikova M, Beaty BL, Meites E, Stokley S, Lindley MC. HPV Vaccine Delivery Practices by Primary Care Physicians. Pediatrics 2019; 144:e20191475. [PMID: 31527175 PMCID: PMC8297056 DOI: 10.1542/peds.2019-1475] [Citation(s) in RCA: 49] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 07/24/2019] [Indexed: 02/06/2023] Open
Abstract
BACKGROUND AND OBJECTIVES To examine, among pediatricians and family physicians (FPs) (1) human papillomavirus (HPV) vaccine delivery practices, (2) delivery experiences, and (3) attitudes regarding new 2-dose HPV vaccination schedules. METHODS We surveyed nationally representative networks of pediatricians and FPs by Internet or mail from July 2018 to September 2018. Multivariable regression was used to assess factors associated with refusal or deferral rates of ≥50% among 11- to 12-year-old patients. RESULTS The response rate was 65% (302 pediatricians and 228 FPs included). Pediatricians who strongly recommended the HPV vaccine ranged from 99% for patients ≥15 years old (female) to 83% for those 11 to 12 years old (male); FPs ranged from 90% for patients ≥15 years old (female) to 66% for those 11 to 12 years old (male) (P < .0001 between specialties). Sixty-five percent of pediatricians and 42% of FPs always or almost always used presumptive style when discussing the HPV vaccine (P < .0001). Overall, 40% used standing orders and 42% had electronic alerts. Among pediatricians, the proportion reporting a refusal or deferral rate ≥50% was 19% for female patients and 23% for male patients 11 to 12 years old; FPs reported 27% and 36%, respectively. In the multivariable regression (both sexes), refusal or deferral was associated with physicians not strongly recommending the HPV vaccine to 11- to 12-year-old patients, not using a presumptive style, perceiving less resistance when introducing the HPV vaccine to a 13-year-old patient versus an 11- or 12-year-old patient, and anticipating an uncomfortable conversation when recommending the HPV vaccine to an 11- or 12-year-old patient. Eighty-nine percent of pediatricians and 79% of FPs reported that more adolescents <15 years old are completing the HPV series now that only 2 doses are recommended. CONCLUSIONS Although most physicians strongly recommend the HPV vaccine to 11- to 12-year-old patients, our data reveal areas for improvement in recommendation and delivery methods. Most physicians perceive that the 2-dose schedule is resulting in higher HPV completion rates.
Collapse
Affiliation(s)
- Allison Kempe
- Adult and Child Consortium for Health Outcomes Research and Delivery Science, School of Medicine, University of Colorado and Children's Hospital Colorado, Aurora, Colorado;
- Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado
| | - Sean T O'Leary
- Adult and Child Consortium for Health Outcomes Research and Delivery Science, School of Medicine, University of Colorado and Children's Hospital Colorado, Aurora, Colorado
- Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado
| | - Lauri E Markowitz
- National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
| | - Lori A Crane
- Adult and Child Consortium for Health Outcomes Research and Delivery Science, School of Medicine, University of Colorado and Children's Hospital Colorado, Aurora, Colorado
- Department of Community and Behavioral Health, Colorado School of Public Health, University of Colorado, Aurora, Colorado; and
| | - Laura P Hurley
- Adult and Child Consortium for Health Outcomes Research and Delivery Science, School of Medicine, University of Colorado and Children's Hospital Colorado, Aurora, Colorado
- Division of General Internal Medicine, Denver Health, Denver, Colorado
| | - Michaela Brtnikova
- Adult and Child Consortium for Health Outcomes Research and Delivery Science, School of Medicine, University of Colorado and Children's Hospital Colorado, Aurora, Colorado
- Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado
| | - Brenda L Beaty
- Adult and Child Consortium for Health Outcomes Research and Delivery Science, School of Medicine, University of Colorado and Children's Hospital Colorado, Aurora, Colorado
| | - Elissa Meites
- National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
| | - Shannon Stokley
- National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
| | - Megan C Lindley
- National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
| |
Collapse
|
3
|
Goldenberg NA, Daniels SR, Mourani PM, Hamblin F, Stowe A, Powell S, Ford DE, Ellen J. Enhanced Infrastructure for Optimizing the Design and Execution of Clinical Trials and Longitudinal Cohort Studies in the Era of Precision Medicine. J Pediatr 2016; 171:300-6.e1-2. [PMID: 26787376 DOI: 10.1016/j.jpeds.2015.12.037] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/17/2015] [Revised: 10/30/2015] [Accepted: 12/15/2015] [Indexed: 01/19/2023]
Affiliation(s)
- Neil A Goldenberg
- Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD; All Children's Hospital Johns Hopkins Medicine and All Children's Research Institute, St. Petersburg, FL.
| | - Stephen R Daniels
- Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO; Children's Hospital Colorado, Aurora, CO
| | - Peter M Mourani
- Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO; Children's Hospital Colorado, Aurora, CO
| | - Frances Hamblin
- All Children's Hospital Johns Hopkins Medicine and All Children's Research Institute, St. Petersburg, FL
| | | | - Sylvia Powell
- Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD; All Children's Hospital Johns Hopkins Medicine and All Children's Research Institute, St. Petersburg, FL
| | - Daniel E Ford
- Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD
| | - Jonathan Ellen
- Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD; All Children's Hospital Johns Hopkins Medicine and All Children's Research Institute, St. Petersburg, FL
| |
Collapse
|
4
|
Byington CL, Maldonado Y. Rotavirus Vaccines-OK to Mix and Match. Pediatrics 2016; 137:e20153618. [PMID: 26823542 PMCID: PMC4732364 DOI: 10.1542/peds.2015-3618] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 11/16/2015] [Indexed: 01/19/2023] Open
Affiliation(s)
| | - Yvonne Maldonado
- Stanford University, Department of Pediatrics, Palo Alto, California
| |
Collapse
|
5
|
Zhang Y, Wang L, Diao T. The quantitative evaluation of the Clinical and Translational Science Awards (CTSA) program based on science mapping and scientometric analysis. Clin Transl Sci 2013; 6:452-7. [PMID: 24330689 DOI: 10.1111/cts.12078] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023] Open
Abstract
The Clinical and Translational Science Awards (CTSA) program is one of the most important initiatives in translational medical funding. The quantitative evaluation of the efficiency and performance of the CTSA program has a significant referential meaning for the decision making of global translational medical funding. Using science mapping and scientometric analytic tools, this study quantitatively analyzed the scientific articles funded by the CTSA program. The results of the study showed that the quantitative productivities of the CTSA program had a stable increase since 2008. In addition, the emerging trends of the research funded by the CTSA program covered clinical and basic medical research fields. The academic benefits from the CTSA program were assisting its members to build a robust academic home for the Clinical and Translational Science and to attract other financial support. This study provided a quantitative evaluation of the CTSA program based on science mapping and scientometric analysis. Further research is required to compare and optimize other quantitative methods and to integrate various research results.
Collapse
Affiliation(s)
- Yin Zhang
- Beijing Institute of Health Administration and Medical Information, Beijing, China
| | | | | |
Collapse
|